abstract |
An object of the present invention is to provide a novel crystalline form of a compound having an activated blood coagulation factor X inhibitory activity useful as a pharmaceutical compound for the prevention and / or treatment of thrombotic and / or embolic diseases. . The present invention, N 1 - (5-chloropyridin-2-yl) -N 2 - ((1S, 2R, 4S) -4 - [( dimethylamino) carbonyl] -2 - {[(5-methyl-4 , 5,6,7-Tetrahydrothiazolo [5,4-c] pyridin-2-yl) carbonyl] amino} cyclohexyl) ethanediamide p-toluenesulfonate monohydrate and a novel process for its preparation Provided. |